The launch of Hillchol comes at a time global demand for OCVs is over 100 million doses a year, and there is a deficit of approximately 40 million doses every year. The vaccine is suitable for individuals one year and older
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.